Asthma medication use | ||
In the past year | In the past 2 months | |
ICS alone | 66 (30.3) | 58 (26.6) |
ICS–LABA | 84 (38.5) | 78 (35.8) |
Inhaled LABA | 0 (0.0) | 0 (0.0) |
Oral LABA | 77 (35.3) | 70 (32.1) |
Patch LABA | 41 (18.8) | 36 (16.5) |
LTRA | 160 (73.4) | 145 (66.5) |
Inhaled SABA | 83 (38.1) | 75 (34.4) |
Oral SABA | 30 (13.8) | 8 (3.7) |
Xanthine | 110 (50.5) | 100 (45.9) |
Inhaled LAMA | 25 (11.5) | 25 (11.5) |
Data are presented as n (%). ICS: inhaled corticosteroid; LABA: long-acting β2-agonist; LTRA: leukotriene receptor antagonist; SABA: short-acting β2-agonist; LAMA: long-acting muscarinic antagonist.